Does tocilizumab mean the end of glucocorticoids in giant cell arteritis?

被引：1
|
作者：
Samson, M. [1 ,2 ,3 ]
Bonnotte, B. [1 ,2 ,3 ]
机构：
[1] CHU Dijon Bourgogne, Serv Med Interne, 2 Blvd Mal de Lattre de Tassigny, F-21000 Dijon, France
[2] CHU Dijon Bourgogne, Immunol Clin, 2 Blvd Mal de Lattre de Tassigny, F-21000 Dijon, France
[3] Univ Bourgogne Franche Comte, FHU Increase, Inserm U1098, F-21000 Dijon, France
来源：
REVUE DE MEDECINE INTERNE | 2018年 / 39卷 / 02期
关键词：
Giant cell arteritis; Treatment; Tocilizumab; LARGE-VESSEL VASCULITIS; TAKAYASU ARTERITIS; DOUBLE-BLIND; THERAPY; TRIAL; ABATACEPT;
D O I：
10.1016/j.revmed.2017.11.003
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：75 / 77
页数：3
相关论文
共 50 条
  • [21] Giant cell arteritis successfully treated with subcutaneous tocilizumab monotherapy
    Misako Higashida-Konishi
    Mitsuhiro Akiyama
    Tatsuya Shimada
    Satoshi Hama
    Tatsuhiro Oshige
    Keisuke Izumi
    Hisaji Oshima
    Yutaka Okano
    Rheumatology International, 2023, 43 : 545 - 549
  • [22] Treatment of Giant Cell Arteritis and Takayasu Arteritis-Current and Future
    Hellmich, B.
    Agueda, A. F.
    Monti, S.
    Luqmani, R.
    CURRENT RHEUMATOLOGY REPORTS, 2020, 22 (12)
  • [23] An agent-to-agent real life comparison study of tocilizumab versus abatacept in giant cell arteritis
    Rossi, D.
    Cecchi, I.
    Sciascia, S.
    Naretto, C.
    Alpa, M.
    Roccatello, D.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2021, 39 (02) : S125 - S128
  • [24] Profile of tocilizumab and its potential in the treatment of giant cell arteritis
    Mollan, Susan Patricia
    Horsburgh, John
    Dasgupta, Bhaskar
    EYE AND BRAIN, 2018, 10 : 1 - 11
  • [25] Recent advances in the treatment of giant cell arteritis
    Springer, Jason M.
    Kermani, Tanaz A.
    BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2023, 37 (01):
  • [26] Giant Cell Arteritis and Takayasu Arteritis: Are They Similar or Different?
    Singh, Yogesh Preet
    Bains, Sukhdeep
    Jain, Naman
    INDIAN JOURNAL OF RHEUMATOLOGY, 2025, 20 (01) : 48 - 59
  • [27] Tocilizumab in Giant Cell Arteritis: A Real-Life Retrospective Study
    Vitiello, Gianfranco
    Battaglini, Carolina Orsi
    Carli, Giulia
    Radice, Anna
    Matucci, Andrea
    Vultaggio, Alessandra
    Olianti, Catia
    Parronchi, Paola
    Maggi, Enrico
    Cammelli, Daniele
    ANGIOLOGY, 2018, 69 (09) : 763 - 769
  • [28] Recent advances in the diagnosis and management of giant cell arteritis
    Serling-Boyd, Naomi
    Stone, John H.
    CURRENT OPINION IN RHEUMATOLOGY, 2020, 32 (03) : 201 - 207
  • [29] Tocilizumab in Giant Cell Arteritis: A Multicenter Retrospective Study of 34 Patients
    Regent, Alexis
    Redeker, Serge
    Deroux, Alban
    Kieffer, Pierre
    Ly, Kim Heang
    Dougados, Maxime
    Liozon, Eric
    Larroche, Claire
    Guillevin, Loic
    Bouillet, Laurence
    Espitia, Olivier
    Costedoat-Chalumeau, Nathalie
    Soubrier, Martin
    Brihaye, Benoit
    Lifermann, Francois
    Lefevre, Guillaume
    Puechal, Xavier
    Mouthon, Luc
    Toussirot, Eric
    JOURNAL OF RHEUMATOLOGY, 2016, 43 (08) : 1547 - 1552
  • [30] Duration of Treatment With Glucocorticoids in Giant Cell Arteritis A Systematic Review and Meta-analysis
    Moreel, Lien
    Betrains, Albrecht
    Molenberghs, Geert
    Blockmans, Daniel
    Vanderschueren, Steven
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2023, 29 (06) : 291 - 297
12345